Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

multidrug-resistant tuberculosis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A narrative review highlights the diagnostic challenges and management strategies for congenital multidrug-resistant tuberculosis (MDR-TB) in extremely low birth weight neonates. This study underscores the complexities faced in treating this vulnerable population.

A study investigates mutations that confer pyrazinamide resistance in multidrug-resistant tuberculosis isolates from China. Understanding these mutations can inform treatment strategies for this challenging disease.

A multicentre field evaluation of the Xpert MTB/XDR test in sub-Saharan Africa highlights its effectiveness in diagnosing multidrug-resistant tuberculosis. This study contributes to the ongoing efforts to improve tuberculosis management in regions heavily impacted by the disease.

The White House has unveiled the 'National Action Plan to Combat Multidrug-Resistant Tuberculosis (MDR TB)', highlighting the urgent need to address this escalating public health threat. This initiative aims to enhance efforts in finding, curing, and preventing tuberculosis.

Not rare diseases news,news about your rare disease.

Earlier

A narrative review highlights the diagnostic challenges and management strategies for congenital multidrug-resistant tuberculosis (MDR-TB) in extremely low birth weight neonates. This study underscores the complexities faced in treating this vulnerable population.

A study investigates mutations that confer pyrazinamide resistance in multidrug-resistant tuberculosis isolates from China. Understanding these mutations can inform treatment strategies for this challenging disease.

A multicentre field evaluation of the Xpert MTB/XDR test in sub-Saharan Africa highlights its effectiveness in diagnosing multidrug-resistant tuberculosis. This study contributes to the ongoing efforts to improve tuberculosis management in regions heavily impacted by the disease.

The White House has unveiled the 'National Action Plan to Combat Multidrug-Resistant Tuberculosis (MDR TB)', highlighting the urgent need to address this escalating public health threat. This initiative aims to enhance efforts in finding, curing, and preventing tuberculosis.

Not rare diseases news,
news about your rare disease.